Short answer: US search interest in tirzepatide - and its shorthand “tirz” - climbed steeply from 2022 alongside the Mounjaro and Zepbound launches and has held high since. Unlike retatrutide, tirzepatide is FDA-approved as a branded medicine - yet the molecule also drives substantial research-compound search. This report tracks search interest, not clinical demand, sales or any endorsement of human use. New-U supplies tirzepatide (catalogued as Tirzepatide) strictly as a research compound for laboratory use.
If retatrutide is the breakout newcomer, tirzepatide is the established blockbuster. On Google Trends for the US, tirzepatide search interest rose steeply from the 2022 Mounjaro launch, accelerated again with Zepbound, and has stayed elevated into 2026. What makes the tirzepatide case instructive is the split it reveals: an FDA-approved branded medicine that also generates heavy interest in the underlying research compound.
How to read these figures. Google Trends reports relative interest on a 0–100 scale, not raw volumes. Tirzepatide’s curve is less a single Breakout spike than a sustained, multi-year climb - the shape of a term that entered the mainstream and stayed. As always, the percentage you might see quoted depends on the window; the reliable read is the durable, elevated trend.
Tirzepatide sits in a different category from retatrutide. It is FDA-approved as Mounjaro (type 2 diabetes) and Zepbound (chronic weight management). But the molecule - LY3298176, a dual GLP-1 / GIP receptor agonist - is also widely studied as a research compound, and that is the supply New-U deals in. The distinction matters:
| Form | What it is | Who supplies it |
|---|---|---|
| Mounjaro / Zepbound | FDA-approved branded tirzepatide medicines | Pharmacies, on prescription |
| Research-grade tirzepatide | The LY3298176 molecule as a lyophilised research compound | Research-compound suppliers - research use only |
New-U supplies the research form only. We do not sell Mounjaro or Zepbound, and we make no human-use claims. For the mechanism-level comparison with the single agonist, see Tirzepatide vs Semaglutide, and for the full molecule profile, the tirzepatide research guide.
Plain-English summary. High search interest in tirzepatide reflects mainstream awareness of the approved brands. New-U’s tirzepatide is the research-grade compound, supplied for laboratory use only, labelled research use only, with no human dosing or therapeutic claims. For anything health-related, consult a licensed clinician.
The supplier bar is documentation: research-use-only labelling, no health claims, a per-batch Certificate of Analysis with HPLC purity (>99% is the credible standard) and mass-spec identity from a named third-party lab, and a verifiable legal entity. On the New-U catalogue, tirzepatide is listed as Tirzepatide, independently verified by Janoshik and Freedom Diagnostics, with a dedicated US page at Buy Tirzepatide in the USA covering FDA framing, USD pricing and tracked delivery (free over $300). The commercial overview is at /peptide/tirzepatide; the full US range at Buy Peptides in the USA.
Tirzepatide’s durable search plateau and retatrutide’s breakout climb are two sides of the same US incretin wave. We map the full picture in Research Peptide Search Demand in the USA, and cover the newcomer’s surge in Why “Reta” Searches Are Surging in the USA.
Is search interest in tirzepatide rising in the USA?
US search interest in tirzepatide and “tirz” climbed steeply from 2022 alongside the Mounjaro and Zepbound launches and has stayed high. This tracks search curiosity, not clinical demand or any endorsement of human use.
Why does an FDA-approved drug also drive research-compound searches?
Tirzepatide is FDA-approved as Mounjaro and Zepbound, but the molecule is also studied as a research compound. As the brands became household names, interest broadened to the underlying compound name and research-grade supply.
How is New-U’s tirzepatide different from Mounjaro or Zepbound?
New-U’s tirzepatide is a research compound for laboratory use only - not an approved branded medicine and not for human use. New-U does not sell Mounjaro or Zepbound.
Does rising search interest mean a research compound is safe to use?
No. Search popularity says nothing about safety or appropriate use. New-U supplies tirzepatide strictly as a research compound, with no human dosing or therapeutic claims.
Search-interest figures are directional and depend on the query and date range chosen in Google Trends; New-U is not affiliated with Google or these organisations and links carry no endorsement. Nothing here is medical advice.
New-U Research Compounds ships research-grade tirzepatide (catalogued as Tirzepatide) to US addresses in sealed 10-vial packs, independently verified by Janoshik and Freedom Diagnostics for >99% purity, with a per-batch Certificate of Analysis. Tracked US delivery, free over $300. Research use only - not for human consumption.
View tirzepatide